From: Antibodies against Hsp60 and Hsp65 in the sera of women with ovarian cancer
 | Phase of antineoplastic treatment | Controls | |
---|---|---|---|
Untreated so far | After chemotherapy | n = 80 | |
n = 72 | n = 77 | ||
Anti-Hsp60 (AU/ml) | 89,59 ± 89,99 | 99,91 ± 158,40 | 62,42 ± 33,93 |
(mean ± SD) | |||
  % of positive results | 28%* | 19% | 10% |
  (> 90 percentile for control group) | p = 0.0041 | p = 0.1085 | |
Anti-Hsp65 (AU/ml) | 80,31 ± 86,71 | 109,64 ± 226,24 | 56,35 ± 35,57 |
(mean ± SD) | |||
  % of positive results | 19% | 22%* | 10% |
  (> 90 percentile for control group) | p = 0.1103 | p = 0.0398 |